about
Recent advances in isolation, synthesis, and evaluation of bioactivities of bispyrroloquinone alkaloids of marine originInitial testing (stage 1) of eribulin, a novel tubulin binding agent, by the pediatric preclinical testing programMarine Antibody-Drug Conjugates: Design Strategies and Research Progress.Eribulin: a new-generation antimicrotubule agent in lung cancer therapy.Emerging treatment using tubulin inhibitors in advanced non-small cell lung cancer.Microtubule destabilising agents: far more than just antimitotic anticancer drugs.RNA-binding protein RBM8A (Y14) and MAGOH localize to centrosome in human A549 cells.Managing sarcoma: where have we come from and where are we going?
P2860
Q26801027-492D2B05-6059-46DC-9A4A-EC3C2E102DB5Q34683835-47DA91E2-DB1A-4C4D-9FC1-C0CA1459B595Q37628646-36CDBEAB-2890-4F21-AADC-3982C25AC680Q38267039-07600875-FE91-4A61-A404-ADDAE9025250Q38847914-997DA061-814E-4FBB-B873-DA9C0B689B0CQ38952778-38E40202-7C85-4FF9-BF1C-783030FA51EDQ39109744-97F5996D-2963-4917-8821-54042F0F7CA8Q41988197-2AF48B93-26AE-4D1C-9FB6-D9D7E388571B
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Eribulin: a novel cytotoxic chemotherapy agent.
@en
type
label
Eribulin: a novel cytotoxic chemotherapy agent.
@en
prefLabel
Eribulin: a novel cytotoxic chemotherapy agent.
@en
P2860
P356
P1476
Eribulin: a novel cytotoxic chemotherapy agent.
@en
P2093
Jessica N Preston
Meghana V Trivedi
P2860
P304
P356
10.1345/APH.1Q636
P407
P577
2012-05-22T00:00:00Z